Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
Boehringer Ingelheim
US Army
Federal Trade Commission
Accenture
AstraZeneca
Daiichi Sankyo
Colorcon

Generated: April 24, 2018

DrugPatentWatch Database Preview

ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Drug Profile

« Back to Dashboard

Which patents cover Rosiglitazone Maleate And Glimepiride, and when can generic versions of Rosiglitazone Maleate And Glimepiride launch?

Rosiglitazone Maleate And Glimepiride is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in ROSIGLITAZONE MALEATE AND GLIMEPIRIDE is glimepiride; rosiglitazone maleate. There are fifteen drug master file entries for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.
Summary for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
Drug patent expirations by year for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

US Patents and Regulatory Information for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa ROSIGLITAZONE MALEATE AND GLIMEPIRIDE glimepiride; rosiglitazone maleate TABLET;ORAL 078709-001 Apr 1, 2016 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ROSIGLITAZONE MALEATE AND GLIMEPIRIDE glimepiride; rosiglitazone maleate TABLET;ORAL 078709-003 Apr 1, 2016 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ROSIGLITAZONE MALEATE AND GLIMEPIRIDE glimepiride; rosiglitazone maleate TABLET;ORAL 078709-002 Apr 1, 2016 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ROSIGLITAZONE MALEATE AND GLIMEPIRIDE glimepiride; rosiglitazone maleate TABLET;ORAL 078709-004 Apr 1, 2016 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Teva
US Army
Medtronic
McKinsey
Cerilliant
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.